AUTHOR=Yan Miaolong , Wu Jiayuan , Xue Min , Mo Juanfen , Zheng Li , Zhang Jun , Gao Zhenzhen , Bao Yi 

TITLE=The Studies of Prognostic Factors and the Genetic Polymorphism of Methylenetetrahydrofolate Reductase C667T in Thymic Epithelial Tumors

JOURNAL=Frontiers in Oncology

VOLUME=12

YEAR=2022

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.847957

DOI=10.3389/fonc.2022.847957

ISSN=2234-943X

ABSTRACT=<sec><title>Objective</title><p>To describe the clinical features of a cohort of patients with thymic epithelial tumors (TETs) and to analyze their prognostic factors. In particular, we investigated the correlation between the genetic polymorphism of methylenetetrahydrofolate reductase (<italic>MTHFR</italic>) C667T and the incidence of TETs.</p></sec><sec><title>Methods</title><p>Pathological records were reviewed from the database of the Second Affiliated Hospital of Jiaxing University, from January 2010 to December 2020, and 84 patients with TETs were recruited for this study. Univariate and multivariate analyses were performed to determine the prognostic factors. The genetic polymorphism of <italic>MTHFR</italic> C667T was examined in the patients with TETs and in a group of healthy individuals. The correlation between <italic>MTHFR</italic> transcriptional levels and methylation was analyzed using The Cancer Genome Atlas (TCGA) thymoma dataset from the cBioPortal platform.</p></sec><sec><title>Results</title><p>Kaplan–Meier univariate survival analysis showed that sex, age, the maximum tumor diameter, surgery, chemotherapy, radiotherapy, WHO histological classification, Masaoka–Koga stage, and 8th UICC/AJCC TNM staging, were statistically significantly correlated with the prognosis of patients with TETs. The Masaoka–Koga stage and 8th UICC/AJCC TNM staging were strongly correlated with each other in this study (r=0.925, P&lt;0.001). Cox multivariate survival analysis showed that the maximum tumor diameter, Masaoka–Koga stage, and 8th UICC/AJCC TNM staging were independent prognostic factors affecting the overall survival (OS) of patients with TETs (<italic>P&lt;</italic>0.05). The <italic>MTHFR</italic> C667T genotype (<italic>χ</italic><sup>2 =</sup> 7.987, <italic>P</italic>=0.018) and allele distribution (<italic>χ</italic><sup>2 =</sup> 5.750, <italic>P=</italic>0.016) were significantly different between the patients and healthy controls. CT heterozygous and TT homozygous genotypes at this <italic>MTHFR</italic> polymorphism significantly increased the risk of TETs (odds ratio [OR] <italic>=</italic>4.721, <italic>P=</italic>0.008). Kaplan–Meier univariate survival analysis showed that there was no correlation between different genotypes and the prognosis of TETs (CC versus CT + TT, <italic>χ<sup>2 =</sup></italic>0.003, <italic>P</italic>=0.959). Finally, a negative correlation between the transcriptional and methylation levels of <italic>MTHFR</italic> was observed in the TCGA thymoma dataset (<italic>r=</italic>-0.24, <italic>P=</italic>0.010).</p></sec><sec><title>Conclusions</title><p>The Masaoka–Koga stage, 8th UICC/AJCC TNM staging, and maximum tumor diameter were independent prognostic factors for TETs. Reduced methylation levels of <italic>MTHFR</italic> and particular polymorphic variants may contribute to the susceptibility to developing TETs.</p></sec>